Atara Biotherapeutics, Inc. (ATRA) stock
ATRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.77+0.27 (+4.15%)
Close on Nov 18, 2026Market cap $67.96MP/E –Yield –
Atara Biotherapeutics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Atara Biotherapeutics
Atara Biotherapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?